Odile Jaume to Lead Telix’s European Operations
Melbourne (Australia) and Brussels (Belgium) – 1st March, 2018. Telix announces the appointment of Ms. Odile Jaume as President and COO of Telix’s European Operations
Telix Pharmaceuticals Limited is delighted to announce the appointment of Ms. Odile Jaume as President and Chief Operating Officer (COO) of Telix’s European operations.
Telix Co-Founder and CEO Dr. Christian Behrenbruch stated, “It’s my great pleasure to welcome Odile to the team, and for her to take charge of our European operations. Europe has a highly sophisticated nuclear medicine ecosystem that Odile knows very well, and we are pleased to have the benefit of her managerial and business development acumen.”
To read the full media release click here.